ASO Author Reflections: Selecting Patients for Elimination of Surgery Trials—Predicting Residual Invasive and In Situ Disease in Patients with HER2-Positive Breast Cancer After Neoadjuvant Systemic Therapy

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)804-805
Number of pages2
JournalAnnals of surgical oncology
Volume26
DOIs
StatePublished - Dec 1 2019

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this